System Scoops Up $20 Million
2026-09-09
Tweet
SAN FRANCISCO, CA, System, the vertically integrated peptide platform, announced $20M in new funding.
System, the vertically integrated peptide platform connecting patients with licensed U.S. clinicians and pharmacy-grade compound treatments, announced $20M in new funding to accelerate its mission of becoming the definitive, trusted name in peptides.
Funding comes from Patron Fund, Will Ventures, Vine, Courtside, Daybreak, SV Angel, and RiverPark Ventures. The fresh capital will give more people access to what has historically been reserved for a select group of patients.
Funding comes from Patron Fund, Will Ventures, Vine, Courtside, Daybreak, SV Angel, and RiverPark Ventures. The fresh capital will give more people access to what has historically been reserved for a select group of patients.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
